Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NF-κB signaling pathways, induced by a variety of triggers, play a key role in regulating the expression of genes involved in the immune response and cellular responses to stress. The human pathogen Helicobacter pylori induces classical and alternative NF-κB signaling pathways via its effector ADP-L-glycero-β-D-manno-heptose (ADP-heptose). We review H. pylori- and NF-κB-dependent alterations in cellular processes and associated maladaptation leading to deleterious gastric pathophysiology that have implications for the diagnosis and treatment of gastric diseases. Therapeutic options for gastric cancer (GC) include clinically relevant small molecule inhibitors of NF-κB and epigenetic therapy approaches. In this context, gastric organoid biobanks originated from patient material, represent a valuable platform for translational applications to predict patient responses to chemotherapy, with a view to personalized medicine.

More information Original publication

DOI

10.1016/j.molmed.2021.12.005

Type

Journal article

Publication Date

2022-03-01T00:00:00+00:00

Volume

28

Pages

210 - 222

Total pages

12

Keywords

ADP-heptose, apoptotic cell death, epigenetic, neoplasia differentiation, polarized gastric monolayer organoid, Gastric Mucosa, Helicobacter Infections, Helicobacter pylori, Humans, NF-kappa B, Signal Transduction, Stomach Neoplasms